We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$87.5B
AUM Growth
+$6.24B
Cap. Flow
-$2.46B
Cap. Flow %
-2.82%
Top 10 Hldgs %
10.13%
Holding
4,337
New
572
Increased
1,477
Reduced
1,498
Closed
412

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$546M
2
AMZN icon
Amazon
AMZN
+$515M
3
TSLA icon
Tesla
TSLA
+$389M
4
NFLX icon
Netflix
NFLX
+$322M
5
ADBE icon
Adobe
ADBE
+$305M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$836M
2
CELG
Celgene Corp
CELG
+$460M
3
NVDA icon
NVIDIA
NVDA
+$429M
4
COP icon
ConocoPhillips
COP
+$311M
5
BIIB icon
Biogen
BIIB
+$301M

Sector Composition

Rank Sector Weight
1 Technology 15.8%
2 Consumer Discretionary 11.76%
3 Healthcare 10.16%
4 Financials 7.89%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTS
3426
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$425K ﹤0.01%
122,091
-101,038
-45% -$293K
TIVO
3427
PUT
DELISTED
Tivo Inc
TIVO
$424K ﹤0.01%
50,000
KMI icon
3428
PUT
Kinder Morgan
KMI
$69.5B
$423K ﹤0.01%
20,000
NRC icon
3429
NRC Health Common Stock
NRC
$488M
$423K ﹤0.01%
6,410
-602
-9% -$36.8K
CME icon
3430
PUT
CME Group
CME
$100B
$422K ﹤0.01%
+2,100
New +$431K
DECK icon
3431
PUT
Deckers Outdoor
DECK
$12.1B
$422K ﹤0.01%
15,000
GYRE icon
3432
Gyre Therapeutics
GYRE
$711M
$422K ﹤0.01%
+8,263
New +$346K
CRC
3433
DELISTED
California Resources Corporation
CRC
$421K ﹤0.01%
+46,650
New +$378K
HTT
3434
CALL
High Templar Tech Ltd
HTT
$391M
$419K ﹤0.01%
+88,900
New +$523K
RCKT icon
3435
Rocket Pharmaceuticals
RCKT
$414M
$419K ﹤0.01%
+18,427
New +$308K
TDOC icon
3436
CALL
Teladoc Health
TDOC
$1.12B
$419K ﹤0.01%
5,000
LEG icon
3437
CALL
Leggett & Platt
LEG
$1.27B
$417K ﹤0.01%
+8,200
New +$402K
RGP icon
3438
Resources Connection
RGP
$147M
$416K ﹤0.01%
+25,483
New +$387K
PDCE
3439
PUT
DELISTED
PDC Energy, Inc.
PDCE
$416K ﹤0.01%
+15,900
New +$382K
TRC icon
3440
Tejon Ranch
TRC
$438M
$415K ﹤0.01%
+25,952
New +$424K
CBIO
3441
Crescent Biopharma
CBIO
$638M
$414K ﹤0.01%
782
+290
+59% +$157K
AIG.WS
3442
DELISTED
American International Group, Inc.
AIG.WS
$414K ﹤0.01%
41,284
BEN icon
3443
CALL
Franklin Templeton
BEN
$17.8B
$413K ﹤0.01%
+15,900
New +$432K
RELX icon
3444
RELX
RELX
$62.5B
$413K ﹤0.01%
16,356
+6,846
+72% +$164K
EXR icon
3445
PUT
Extra Space Storage
EXR
$30.6B
$412K ﹤0.01%
3,900
FFWM
3446
DELISTED
First Foundation Inc
FFWM
$411K ﹤0.01%
23,634
+1,542
+7% +$24.8K
FLNT
3447
Fluent
FLNT
$129M
$411K ﹤0.01%
27,400
+8,132
+42% +$110K
UNIT
3448
PUT
Uniti Group
UNIT
$2.44B
$411K ﹤0.01%
50,000
-20,000
-29% -$145K
CASS icon
3449
Cass Information Systems
CASS
$726M
$410K ﹤0.01%
+7,094
New +$397K
CENT icon
3450
Central Garden & Pet Co
CENT
$2.76B
$409K ﹤0.01%
16,435
-616
-4% -$14.7K

Similar funds

David Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
  • David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
  • David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
  • David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
  • David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
  • David Shaw opened 572 new positions and closed 412 in Q4 2019.
  • David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.